RE:Results Better than expected at $2.35 Normalized EPS$270 million free cash in the quarter.
Paid down debt. Improved leverage. Expect more of the same in Q4.
On the conference call in the Q&A they confirmed active NCIB starting on the 15th. To start immediately.
Macdon clearly a crown jewel.
Outperformimg competitors in all 3 segments. (Compare to Martinrea's result which had significant decrease in sales and earnings with a highly levered balance sheet).
Opportunity to increase market share with stressed suppliers.
On track for > $10 EPS in 24